Principal Investigator
Dr. Kirsten Peacey started her career in pharmaceutical medicine in 2018, acting as principal and sub-investigator on a broad range of phase 2-4 clinical trials. She has gained experience in various therapeutic areas including cardiovascular disease, MASH, obesity, vaccines, COPD, asthma, psoriasis, and chronic kidney disease. In 2023 she completed her Advanced Postgraduate Diploma in Pharmaceutical Medicine through the James Lind Institute. Prior to her career in clinical research, Dr. Peacey served her local community as a general practitioner, gaining a solid foundation to manage a wide range of pathology.
